Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“The Body’s Cellular Repair Crew, Mesenchymal stem cells (MSCs) are some of the most fascinating cells in regenerative medicine.
Found in bone marrow, fat tissue, umbilical cord tissue, and other organs, these cells can both transform into specialized cell types and influence healing through powerful signaling mechanisms.
What makes MSCs especially interesting is that their therapeutic potential may come less from ‘becoming new tissue’ and more from how they communicate with the immune system and damaged cells around them.
What MSCs can do:
- Modulate inflammation and immune responses
- Support tissue repair and wound healing
- Differentiate into bone, cartilage, muscle, and fat cells
- Release growth factors and extracellular vesicles that influence surrounding cells
- Serve as a major focus of regenerative medicine and bioengineering research
Researchers are actively studying MSCs in areas ranging from neurodegenerative disease and stroke recovery to orthopedic injury, autoimmune disorders, and cardiovascular disease.
The video of MSCs in motion is a reminder that biology is incredibly dynamic at the microscopic scale. These aren’t static structures — they constantly migrate, interact, signal, and adapt to their environment.
One of the most exciting shifts in recent years has been the growing understanding that stem cell therapies may work through entire cellular ecosystems, not just through cell replacement alone.
Credit to Nanolive SA for the great video!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation